Oxana Beskrovnaya
CIK 1824542 · Chief Scientific Officer · last filed 2025-03-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DYN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
830 WINTER STREET
WALTHAM, MA 02451
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Scientific Officer | 195,840 | $16.09 | $3.15M | -$3.50M | 31 | 2025-03-13 |
Recent Filings · Page 4 of 5
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-04 | DYN | Mixed10b5-1 Plan adopted Jun 30, 2023 |
−19,779 | -$1.56M | EDGAR |
| 2024-01-04 | DYN | Notice (144) Officer · Planned Jan 4, 2024 · 10b5-1 plan Sold: Form 4 filed Jan 4, 2024 |
−42,453 | -$769.7K | EDGAR |
| 2024-01-03 | DYN | Notice (144) Officer · Planned Jan 3, 2024 · 10b5-1 plan Sold: Form 4 filed Jan 4, 2024 |
−45,326 | -$860.4K | EDGAR |
| 2023-12-12 | DYN | Sell (S) | −1,467 | -$15.7K | EDGAR |
| 2023-11-16 | DYN | Grant (A) | +93,718 | $0 | EDGAR |
| 2023-09-20 | DYN | Sell (S) | −1,436 | -$13.5K | EDGAR |
| 2023-09-13 | DYN | Sell (S) | −1,484 | -$15.4K | EDGAR |
| 2023-06-14 | DYN | Sell (S) | −1,475 | -$18.3K | EDGAR |
| 2023-03-15 | DYN | Sell (S) | −1,416 | -$18.9K | EDGAR |
| 2022-12-13 | DYN | Mixed | +39,320 | -$7.4K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
2 sales · $45.2K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2025-06-05 | DYN | 1,093 | $14.6K | $13.35 | 2025-06-11 |
| 2025-05-16 | DYN | 2,589 | $30.6K | $11.82 | 2025-06-05 |